RedHill
RedHill is an Israel-based biopharmaceutical firm that develops and commercializes novel therapeutics for the treatment of gastrointestinal and infectious diseases.
Business Model:
Revenue: $76.3M
Employees: 51-200
Industries / Tags:
Detailed RedHill Information
Geographic Data
Address: 21 Ha’arba’a Street
City: Tel Aviv
State: tel aviv district
Zip: 6473921
Country: IL
Financial Info
Stage:
post ipo equity
Raised Last:
$15M
Raised Total:$216M
Social
Metrics
3,372,930Website Global Rank
4,368Website Monthly Traffic
Twitter Followers
Description
RedHill is an Israel-based biopharmaceutical firm that develops and commercializes novel therapeutics for the treatment of gastrointestinal and infectious diseases.
Contact Phone:
Contact Email:
RedHill went public on 1/18/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/18/2013
Ticker Symbol:
RDHL
Amount Raised:
$13M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2014 | Post-IPO Equity | 2 | $11.7M |
Yelin Lapidot Investment House Migdal Insurance and Financial Holdings Yelin Lapidot Investment House Migdal Insurance and Financial Holdings |
12/2022 | Post-IPO Equity | $8M | 5/2022 | Post-IPO Equity | $15M | 11/2021 | Post-IPO Equity | $15.5M | 3/2021 | Post-IPO Equity | $35M | 11/2010 | Venture Round | 4 | $10M |
Shmuel Kabili Lautman Foundation Fischer Pharmaceutical Laboratories Ltd Fidelity Ventures Shmuel Kabili Lautman Foundation Fischer Pharmaceutical Laboratories Ltd Fidelity Ventures |
11/2019 | Post-IPO Equity | $48.3M | 7/2015 | Post-IPO Equity | 4 | $40M |
ROTH Capital Partners H. C. Wainwright &a; Co. Nomura MLV &a; Co. ROTH Capital Partners H. C. Wainwright &a; Co. Nomura MLV &a; Co. |
12/2018 | Post-IPO Equity | $20M | 11/2021 | Post-IPO Equity | $0 |
Kukbo Kukbo Kukbo Kukbo |
10/2009 | Seed Round | 1 | - |
Saar Wilf Saar Wilf |
11/2021 | Private Placement | $5M | 12/2022 | Post-IPO Equity | $8M | 1/2021 | Post-IPO Equity | $25M | 12/2013 | Post-IPO Equity | 2 | $8.5M |
OrbiMed Broadfin Capital OrbiMed Broadfin Capital |
12/2016 | Post-IPO Equity | $38M | 11/2021 | Post-IPO Equity | 1 | $10M |
Kukbo Kukbo Kukbo Kukbo |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
